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journal homepage: www.e- jmii .comCORRESPONDENCECoinfection of Pneumocystis jiroveci
pneumonia and pulmonary tuberculosis
in a non-HIV-infected patientDear Editor,
We fervently read the article by Li et al1 in the Journal of
Microbiology, Immunology and Infection, in which the au-
thors reported that Pneumocystis jiroveci pneumonia (PJP)
diagnosed late in nonhuman immunodeficiency virus (HIV)-
infected populations has poor outcomes. The incidence
rate of PJP in non-HIV-infected populations is uncertain
because PJP is difficult to diagnose. In this paper, we report
a non-HIV-infected patient admitted to an intensive care
unit who was diagnosed as having a PJP and pulmonary
tuberculosis coinfection. Although we initiated the stan-
dard treatment for PJP and pulmonary tuberculosis and
prescribed potent antibiotics to prevent other possible
bacterial and fungal infections, the patient died because of
fungemia.
An 89-year-old woman with a history of osteoporosis was
admitted because of a recent onset of fever, cough, pro-
gressive dyspnea, and general malaise for 1 week. She had
a low body mass index (13.1 kg/m2), and diffuse retic-
ulonodular opacities on chest radiographies were detected.
Lymphocytopenia (lymphocyte count, 62/mL; CD4þ T cell
count, 59 cells/mL) was observed upon admission, and a
chest computed tomography scan revealed bilateral patchy
ground-glass opacities (Fig. 1). Results of her serologic tests
were negative for HIV antibodies and negative for B and C
viral hepatitis. No malignancy was identified. Acute hypoxic
respiratory failure developed on Day 5 of admission, and
invasive mechanical ventilation was applied. Conducting a
sputum acid-fast stain through transtracheal suction
revealed positive readings, and subsequently, Mycobacte-
rium tuberculosis was identified by conducting a culture
test. Using bronchial washing fluid with cell block yielded a
positive Gomori’s methenamine silver stain with a structure
that revealed a typical P. jiroveci cyst. We began admin-
istering the standard treatment for tuberculosis and PJP onhttp://dx.doi.org/10.1016/j.jmii.2014.07.001
1684-1182/Copyright ª 2014, Taiwan Society of Microbiology. PublishedDay 6 of admission, and the patients’ general condition
improved slightly. However, although we administered
potent antibiotics for pulmonary tuberculosis and PJP and
to prevent other possible bacterial and fungal infections,
septic shock developed. Despite the aggressive treatment,
the patient eventually died because of fungemia.
P. jiroveci and M. tuberculosis are common opportu-
nistic infections in patients infected with HIV, and other
immunosuppressed patients may become infected with
these bacteria. PJP is a severe and potentially lethal
opportunistic infection.1 However, concurrent pulmonary
infections with P. jiroveci and M. tuberculosis in HIV-
seronegative patients is extremely rare, and sporadic
cases involving HIV-negative patients have been published.2
Diagnosing PJP is challenging because of the lack of a
reliable culture system for P. jiroveci and the low sensi-
tivity of conventional staining.1 We describe a case of
concurrent PJP and pulmonary tuberculosis infection in
acute hypoxic respiratory failure without any underlying
diseases, but with CD4þ T-cell depletion and malnutrition.
The predisposing factors for cell-mediated immunodefi-
ciency include steroid therapy (alone or with chemo-
therapy), alcohol-related hepatic cirrhosis, severe
malnutrition, visceral leishmaniasis, pancytopenia, and
CD4þ T lymphocytopenia.2,3 Our patient did not exhibit any
evidence of disease-associated CD4þ T lymphocytopenia,
and she did not receive immunosuppressive therapy. Lym-
phocytopenia was reported to occur in several chronic M.
tuberculosis infections.2 M. tuberculosis actively promotes
down-modulatory mediators to counteract Th1-type and
innate immunity.4
Previous studies have described the association between
tuberculosis and CD4þ T lymphocytopenia, especially that
in HIV infections; however, it remains unclear whether the
low count is a result of tuberculosis or a predisposing factorby Elsevier Taiwan LLC. All rights reserved.
Figure 1. Chest CT revealed bilateral patchy ground-glass
opacity.
712 Correspondencein non-HIV-infected patients.3,5 By contrast, in our case, it
is likely that the coexistence of CD4þ T lymphocytopenia
and malnutrition affected our patient’s immune system.
Thus, the low CD4þ T cell count facilitated the develop-
ment of an opportunistic P. jiroveci infection.6
Li et al1 and other previous studies have reported that
PJP can be more fulminant among immunosuppressed non-
HIV-infected patients than among HIV-infected patients,
resulting in high mortality rates of 50e90%, and a greater
degree of lymphocytopenia has been associated with mor-
tality in non-HIV-infected patients with PJP.1 In addition, Li
et al1 determined that a delay in anti-PJP treatment was
more common among non-HIV-infected patients than
among HIV-infected patients. We observed that our patient
had severe hypoxemia during intensive care unit admission,
and the initiation of her PJP treatment was delayed. Lym-
phocytopenia was observed upon hospitalization, and the
patient died 3 weeks after disease management was
initiated.
In conclusion, pulmonary coinfections of P. jiroveci and
M. tuberculosis in non-HIV-infected patients are rare.
Moreover, PJP in non-HIV-infected patients is extremely
severe, and is associated with higher mortality than that in
HIV-infected patients. Thus, we must be attentive to the
possibility that non-HIV-infected patients with progressive
dyspnea and bilateral patchy ground-glass pulmonaryinfiltration may develop PJP. In addition, rapid and sensi-
tive diagnostic assays to confirm or rule out PJP are
imperatively required to improve prognosis and prevent
unnecessary administration of medication to immunocom-
promised patients. Early diagnosis and initiating treatments
early may improve patient outcomes.
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